1-1 of 1
Yeqian Q. Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD

Available to Purchase
Clinical Trials & Observations
Yanmin M. Zhao, Yi Luo, Jimin M. Shi, Shunqing Q. Wang, Caixia K. Wang, Erlie L. Jiang, Chen Liang, Xiaoyu Y. Zhu, Xuejun J. Zhang, Fankai K. Meng, Hua Jin, Yeqian Q. Zhao, Jian Yu, Xiaoyu Y. Lai, Lizhen Z. Liu, Huarui R. Fu, Yishan S. Ye, Congxiao X. Zhang, Tao Wang, Lifan F. Tu, Xunqiang Q. Wang, He Huang
Journal: Blood
Blood (2025) 145 (24): 2857–2872.
https://doi.org/10.1182/blood.2024026581
Published: 2025
Includes: Supplemental data